Class 4 medicines defect information: Bleo-Kyowa Powder for Solution Injection 15,000IU

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 medicines defect information drug alert for Bleo-Kyowa, Powder for Solution Injection.
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news